tryptophan has been researched along with Tauopathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ano, Y; Nakayama, H; Ohya, R; Takaichi, Y; Takashima, A; Uchida, K | 1 |
| Galba, J; Kovac, A; Michalicova, A; Novak, M; Parrak, V | 1 |
| Abu-Hussien, M; Alyagor, I; Eisenbaum, T; Frenkel-Pinter, M; Gazit, E; Scherzer-Attali, R; Segal, D; Tal, S | 1 |
3 other study(ies) available for tryptophan and Tauopathies
| Article | Year |
|---|---|
Tryptophan-tyrosine dipeptide improves tau-related symptoms in tauopathy mice.
Topics: Alzheimer Disease; Animals; Dipeptides; Disease Models, Animal; Mice; Mice, Transgenic; tau Proteins; Tauopathies; Tryptophan; Tyrosine | 2023 |
Quantitative analysis of phenylalanine, tyrosine, tryptophan and kynurenine in rat model for tauopathies by ultra-high performance liquid chromatography with fluorescence and mass spectrometry detection.
Topics: Animals; Chromatography, High Pressure Liquid; Disease Models, Animal; Humans; Kynurenine; Phenylalanine; Rats; Rats, Inbred SHR; Rats, Transgenic; Tandem Mass Spectrometry; Tauopathies; Tryptophan; Tyrosine | 2016 |
Cl-NQTrp Alleviates Tauopathy Symptoms in a Model Organism through the Inhibition of Tau Aggregation-Engendered Toxicity.
Topics: Alzheimer Disease; Animals; Animals, Genetically Modified; Disease Models, Animal; Drosophila melanogaster; Eye; Naphthalenes; Neuroprotective Agents; Peptide Fragments; tau Proteins; Tauopathies; Tryptophan | 2017 |